Restricted accessResearch articleFirst published online 2023-08
Artificial Downregulation of Ribosomal Protein L34 Restricts the Proliferation and Metastasis of Colorectal Cancer by Suppressing the JAK2/STAT3 Signaling Pathway
The highly conserved ribosomal protein L34 (RPL34) has been reported to play an essential role in the progression of diverse malignancies. RPL34 is aberrantly expressed in multiple cancers, although its significant in colorectal cancer (CRC) is currently unclear. Here, we demonstrated that RPL34 expression was higher in CRC tissues than in normal tissues. Upon RPL34 overexpression, the ability of proliferation, migration, invasion, and metastasis of CRC cells were significantly enhanced in vitro and in vivo. Furthermore, high expression of RPL34 accelerated cell cycle progression, activated the JAK2/STAT3 signaling pathway, and induced the epithelial-to-mesenchymal transition (EMT) program. Conversely, RPL34 silencing inhibited the CRC malignant progression. Utilizing immunoprecipitation assays, we identified the RPL34 interactor, the cullin-associated NEDD8-dissociated protein 1 (CAND1), which is a negative regulator of cullin-RING ligases. CAND1 overexpression reduced the ubiquitin level of RPL34 and stabilized RPL34 protein. CAND1 silencing in CRC cells resulted in a decrease in the ability of proliferation, migration, and invasion. CAND1 overexpression promoted CRC malignant phenotypes and induced EMT, and RPL34 knockdown rescued CAND1-induced CRC progression. In summary, our study indicates that RPL34 acts as a mediator, is stabilized by CAND1, and promotes proliferation and metastasis, in part, through the activation of the JAK2/STAT3 signaling pathway and induction of EMT in CRC.
SiegelRL, MillerKD, FedewaSA, et al.Colorectal cancer statistics, 2017. CA Cancer J Clin, 2017; 67(3):177–193; doi: 10.3322/caac.21395
3.
La VecchiaS, SebastiánC. Metabolic pathways regulating colorectal cancer initiation and progression. Semin Cell Dev Biol, 2020; 98:63–70; doi: 10.1016/j.semcdb.2019.05.018
4.
KangJ, BrajanovskiN, ChanKT, et al.Ribosomal proteins and human diseases: Molecular mechanisms and targeted therapy. Signal Transduct Target Ther, 2021; 6(1):323; doi: 10.1038/s41392-021-00728-8
5.
PecoraroA, PaganoM, RussoG, et al.Ribosome biogenesis and cancer: Overview on ribosomal proteins. Int J Mol Sci, 2021; 22(11):5496; doi: 10.3390/ijms22115496
6.
AkanumaG, NanamiyaH, NatoriY, et al.Inactivation of ribosomal protein genes in Bacillus subtilis reveals importance of each ribosomal protein for cell proliferation and cell differentiation. J Bacteriol, 2012; 194(22):6282–6291; doi: 10.1128/JB.01544-12
7.
DevittML, StafstromJP. Cell cycle regulation during growth-dormancy cycles in pea axillary buds. Plant Mol Biol, 1995; 29(2):255–265; doi: 10.1007/BF00043650
8.
PanagiotidisCA, HuangSC, CanellakisES. Relationship of the expression of the S20 and L34 ribosomal proteins to polyamine biosynthesis in Escherichia coli. Int J Biochem Cell Biol, 1995; 27(2):157–168; doi: 10.1016/1357-2725(94)00068-m
9.
ZhuY, RenC, JiangD, et al.RPL34-AS1-induced RPL34 inhibits cervical cancer cell tumorigenesis via the MDM2–P53 pathway. Cancer Sci, 2021; 112(5):1811–1821; doi: 10.1111/cas.14874
10.
YangS, CuiJ, YangY, et al.Over-expressed RPL34 promotes malignant proliferation of non-small cell lung cancer cells. Gene, 2016; 576(1 Pt 3):421–428; doi: 10.1016/j.gene.2015.10.053
11.
WatanabeS, FujiyamaH, TakafujiT, et al.GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. J Cell Sci, 2018; 131(15):jcs213009; doi: 10.1242/jcs.213009
12.
SungM-K, ReitsmaJM, SweredoskiMJ, et al.Ribosomal proteins produced in excess are degraded by the ubiquitin-proteasome system. Mol Biol Cell, 2016; 27(17):2642–2652; doi: 10.1091/mbc.E16-05-0290
13.
NakayamaKI, NakayamaK. Ubiquitin ligases: Cell-cycle control and cancer. Nat Rev Cancer, 2006; 6(5):369–381; doi: 10.1038/nrc1881
14.
ZemlaA, ThomasY, KedzioraS, et al.CSN- and CAND1-dependent remodelling of the budding yeast SCF complex. Nat Commun, 2013; 4:1641; doi: 10.1038/ncomms2628
15.
LyapinaS, CopeG, ShevchenkoA, et al.Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science, 2001; 292(5520):1382–1385; doi: 10.1126/science.1059780
16.
EigentlerA, TymoszukP, ZwickJ, et al.The impact of Cand1 in prostate cancer. Cancers (Basel), 2020; 12(2):428; doi: 10.3390/cancers12020428
17.
NakashimaK, TakeuchiS, IwamaS, et al.Cullin-associated NEDD8-dissociated protein 1, a novel interactor of rabphilin-3A, deubiquitylates rabphilin-3A and regulates arginine vasopressin secretion in PC12 cells. Endocr J, 2018; 65(3):325–334; doi: 10.1507/endocrj.EJ17-0399
18.
KajihoH, YamamotoY, SakisakaT. CAND1 regulates lunapark for the proper tubular network of the endoplasmic reticulum. Sci Rep, 2019; 9(1):13152; doi: 10.1038/s41598-019-49542-x
19.
TanakaT, NakataniT, KamitaniT. Negative regulation of NEDD8 conjugation pathway by novel molecules and agents for anticancer therapy. Curr Pharm Des, 2013; 19(22):4131–4139; doi: 10.2174/1381612811319220017
20.
BursaćS, ProdanY, PullenN, et al.Dysregulated ribosome biogenesis reveals therapeutic liabilities in cancer. Trends Cancer, 2021; 7(1):57–76; doi: 10.1016/j.trecan.2020.08.003
21.
ZhangX, HuF, LiG, et al.Human colorectal cancer-derived mesenchymal stem cells promote colorectal cancer progression through IL-6/JAK2/STAT3 signaling. Cell Death Dis, 2018; 9(2):25; doi: 10.1038/s41419-017-0176-3
22.
WeiC, YangC, WangS, et al.Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Mol Cancer, 2019; 18(1):64; doi: 10.1186/s12943-019-0976-4
23.
BennettEJ, RushJ, GygiSP, et al.Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics. Cell, 2010; 143(6):951–965; doi: 10.1016/j.cell.2010.11.017
24.
WuY, YangS, MaJ, et al.Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level. Cancer Discov, 2022; 12(1):134–153; doi: 10.1158/2159-8290.CD-21-0316
25.
LeGolvanMP, ResnickM. Pathobiology of colorectal cancer hepatic metastases with an emphasis on prognostic factors. J Surg Oncol, 2010; 102(8):898–908; doi: 10.1002/jso.21817
26.
LiC, GeM, YinY, et al.Silencing expression of ribosomal protein L26 and L29 by RNA interfering inhibits proliferation of human pancreatic cancer PANC-1 cells. Mol Cell Biochem, 2012; 370(1–2):127–139; doi: 10.1007/s11010-012-1404-x
27.
LuoS, ZhaoJ, FowdurM, et al.Highly expressed ribosomal protein L34 indicates poor prognosis in osteosarcoma and its knockdown suppresses osteosarcoma proliferation probably through translational control. Sci Rep, 2016; 6:37690; doi: 10.1038/srep37690
28.
KimJ-H, YouK-R, KimIH, et al.Over-expression of the ribosomal protein L36a gene is associated with cellular proliferation in hepatocellular carcinoma. Hepatology, 2004; 39(1):129–138; doi: 10.1002/hep.20017
29.
ShenD-W, LiangX-J, SuzukiT, et al.Identification by functional cloning from a retroviral cDNA library of cDNAs for ribosomal protein L36 and the 10-kDa heat shock protein that confer cisplatin resistance. Mol Pharmacol, 2006; 69(4):1383–1388; doi: 10.1124/mol.105.017525
30.
FanH, LiJ, JiaY, et al.Silencing of ribosomal protein L34 (RPL34) inhibits the proliferation and invasion of esophageal cancer cells. Oncol Res, 2017; 25(7):1061–1068; doi: 10.3727/096504016X14830466773541
31.
BublikDR, BursaćS, ShefferM, et al.Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival. Proc Natl Acad Sci U S A, 2017; 114(4):E496–E505; doi: 10.1073/pnas.1614876114
32.
DuC, WangT, JiaJ, et al.Suppression of RPL34 inhibits tumor cell proliferation and promotes apoptosis in glioblastoma. Appl Biochem Biotechnol, 2022; 194(8):3494–3506; doi: 10.1007/s12010-022-03857-0
33.
GongZ, LiJ, CangP, et al.RPL34-AS1 functions as tumor suppressive lncRNA in esophageal cancer. Biomed Pharmacother, 2019; 120:109440; doi: 10.1016/j.biopha.2019.109440
34.
WeiF, DingL, WeiZ, et al.Ribosomal protein L34 promotes the proliferation, invasion and metastasis of pancreatic cancer cells. Oncotarget, 2016; 7(51):85259–85272; doi: 10.1863/2/oncotarget.13269
PastushenkoI, BlanpainC. EMT transition states during tumor progression and metastasis. Trends Cell Biol, 2019; 29(3):212–226; doi: 10.1016/j.tcb.2018.12.001
37.
KrebsAM, MitschkeJ, Lasierra LosadaM, et al.The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat Cell Biol, 2017; 19(5):518–529; doi: 10.1038/ncb3513
38.
LiuM, LiH, ZhangH, et al.RBMS1 promotes gastric cancer metastasis through autocrine IL-6/JAK2/STAT3 signaling. Cell Death Dis, 2022; 13(3):287; doi: 10.1038/s41419-022-04747-3
39.
Schulz-HeddergottR, StarkN, EdmundsSJ, et al.Therapeutic ablation of gain-of-function mutant p53 in colorectal cancer inhibits Stat3-mediated tumor growth and invasion. Cancer Cell, 2018; 34(2):298; doi: 10.1016/j.ccell.2018.07.004
40.
WangL-N, ZhangZ-T, WangL, et al.TGF-β1/SH2B3 axis regulates anoikis resistance and EMT of lung cancer cells by modulating JAK2/STAT3 and SHP2/Grb2 signaling pathways. Cell Death Dis, 2022; 13(5):472; doi: 10.1038/s41419-022-04890-x
41.
JiP, WangL, LiuJ, et al.Knockdown of RPL34 inhibits the proliferation and migration of glioma cells through the inactivation of JAK/STAT3 signaling pathway. J Cell Biochem, 2019; 120(3):3259–3267; doi: 10.1002/jcb.27592
42.
CheZ, LiuF, ZhangW, et al.Targeting CAND1 promotes caspase-8/RIP1-dependent apoptosis in liver cancer cells. Am J Transl Res, 2018; 10(5):1357–1372.
43.
AlhammadR. Bioinformatics analysis of the prognostic significance of CAND1 in ERα-positive breast cancer. Diagnostics (Basel), 2022; 12(10):2327; doi: 10.3390/diagnostics12102327
44.
KangM, LiY, ZhaoY, et al.miR-33a inhibits cell proliferation and invasion by targeting CAND1 in lung cancer. Clin Transl Oncol, 2018; 20(4):457–466; doi: 10.1007/s12094-017-1730-2
45.
KorzeniewskiN, HohenfellnerM, DuensingS. CAND1 promotes PLK4-mediated centriole overduplication and is frequently disrupted in prostate cancer. Neoplasia, 2012; 14(9):799–806; doi: 10.1593/neo.12580
46.
ChenT, JinlinD, WangF, et al.GSTM3 deficiency impedes DNA mismatch repair to promote gastric tumorigenesis via CAND1/NRF2-KEAP1 signaling. Cancer Lett, 2022; 538:215692; doi: 10.1016/j.canlet.2022.215692
47.
PierceNW, LeeJE, LiuX, et al.Cand1 promotes assembly of new SCF complexes through dynamic exchange of F box proteins. Cell, 2013; 153(1):206–215; doi: 10.1016/j.cell.2013.02.024
48.
NgASN, ZhangS, MakVCY, et al.AKTIP loss is enriched in ERα-positive breast cancer for tumorigenesis and confers endocrine resistance. Cell Rep, 2022; 41(11):111821; doi: 10.1016/j.celrep.2022.111821
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
